SELLAS LIFE SCIENCES GROUP I's ticker is SLS and the CUSIP is 81642T209. A total of 29 filers reported holding SELLAS LIFE SCIENCES GROUP I in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,783 | +33.7% | 9,014 | +28.0% | 0.00% | – |
| Q2 2023 | $11,057 | +92041.7% | 7,043 | -17.9% | 0.00% | – |
| Q1 2023 | $12 | +300.0% | 8,576 | +611.1% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 1,206 | -55.0% | 0.00% | – |
| Q3 2022 | $5,000 | -37.5% | 2,681 | -28.6% | 0.00% | – |
| Q2 2022 | $8,000 | +166.7% | 3,755 | +709.3% | 0.00% | – |
| Q1 2022 | $3,000 | -40.0% | 464 | -48.1% | 0.00% | – |
| Q4 2021 | $5,000 | -82.1% | 894 | -71.1% | 0.00% | -100.0% |
| Q3 2021 | $28,000 | +600.0% | 3,090 | +724.0% | 0.00% | – |
| Q2 2021 | $4,000 | -66.7% | 375 | -72.3% | 0.00% | – |
| Q1 2021 | $12,000 | +71.4% | 1,354 | +6.8% | 0.00% | – |
| Q4 2020 | $7,000 | +600.0% | 1,268 | +175.7% | 0.00% | – |
| Q3 2020 | $1,000 | -80.0% | 460 | -73.4% | 0.00% | – |
| Q2 2020 | $5,000 | – | 1,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,250,000 | $1,787,500 | 0.02% |
| Alyeska Investment Group, L.P. | 1,000,000 | $1,430,000 | 0.01% |
| Opus Capital Group, LLC | 25,000 | $36 | 0.01% |
| Equitable Holdings, Inc. | 130,000 | $185,900 | 0.00% |
| VANGUARD GROUP INC | 896,912 | $1,282,584 | 0.00% |
| WealthPLAN Partners, LLC | 1 | $1 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,660 | $2,373 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 31,304 | $44,765 | 0.00% |
| WELLS FARGO & COMPANY/MN | 16,142 | $23,083 | 0.00% |
| NORTHERN TRUST CORP | 30,018 | $42,926 | 0.00% |